My father's been using it since April. It's a little cumbersome and only improves overall survival rates by about two months over chemo alone, but we're hoping that it helps him remain relatively healthy until Daraxonrasib becomes available.
I was livid when I discovered that my carrier had implemented that with no opt out. I worked around it by implementing shortcuts that disable my iPhone's WiFi when I leave my house until I've returned or reached one of the handful of other places I use it. It's ridiculous that something like that is necessary, though.
My wife and I had a great time wandering around the Underground City when we visited Montreal. We were there in the fall, but it sunk in just how cold Montreal winters get when we went to a club that had a coatroom the size of my first apartment.
> Around the world, border agencies overwhelmingly focus on imports, hunting for people and drugs. In many countries, exports are hardly checked at all. Anyone can book a container.
I've called 911 twice for borderline issues and it played out both times just like you said - I said what I was seeing and to let me know if I should call a different line, they confirmed the issues were emergencies, and the rest played out like any other 911 call. Let the dispatcher decide.
On a related note, the valid reasons to call 911 are:
1. A danger to life, property or the environment
2. A crime in progress
3. Someone having a medical emergency who needs immediate assistance
It's an extra step, but a surprisingly simple one. When I opened a checking account recently the bank told me which credit agency they'd use, and I unfroze that account and ChexSystems (another credit agency you should freeze with that is used specifically for new bank accounts) in five minutes using their automated systems. You can supply a re-freeze date when unfreezing as well so you don't need to remember to do that manually once you're approved.
Most of the article is about Gehrke and King, but the last fraud case mentioned is absolutely vile:
> Another case alleges a scheme in Florida to distribute misbranded HIV drugs. Prosecutors say drugs were bought on the black market and resold to unsuspecting pharmacies, which then provided the medications to patients.
> Some patients were given bottles that contained different drugs than the label showed. One patient ended up unconscious for 24 hours after taking what he was led to believe was his HIV medication but was actually an anti-psychotic drug, prosecutors say.
When I was a kid HP products were well-supported and famed for their durability. My dad still uses the HP scientific calculator his father bought in the '70s and my uncle has an old PC hooked up to a '90s LaserJet printer that works perfectly well. Retired engineers I've talked to gush about working there in the HP Way days, they were respected and got to create fantastic products that their customers loved.
Now "HP" is a curse word to anyone in tech. It's a damn shame.
I hadn't thought about Freehand in a decade and now I'm angry at Adobe for killing it all over again. It never got in your way and let you fully focus on your work. Illustrator never lets you forget that you're using a tool to create things like Freehand did.
It's interesting to see a post here that flips the script a little, focusing on the negative consequences of growth-at-all-costs for those attempting to create good journalism and reviews as opposed to those seeking to consume them. We don't get that perspective often on a tech-focused site like HN.
It is bizarre that new media companies are funded, staffed, and run with the expectation that they'll scale and profit on the level of successful tech companies. Original, credible content takes smart, trained people time to produce, and you can't scale the business without scaling the number of such people doing that work. You can't automate or leverage AI to cultivate trustworthy news sources or investigate a corrupt sheriff's department. I don't know what business model would work above the micro Substack-funded level, but it's clear that the one that keeps being tried never will.
Same here. Are you and your care recipient familiar with the Optune Pax device that the FDA approved in February?
https://www.fda.gov/news-events/press-announcements/fda-appr...
My father's been using it since April. It's a little cumbersome and only improves overall survival rates by about two months over chemo alone, but we're hoping that it helps him remain relatively healthy until Daraxonrasib becomes available.